Recent studies show age-related gut microbiome changes, such as Klebsiella aerogenes overgrowth, increase histamine production, leading to barrier dysfunction and inflammation, raising sepsis risk. In...
Recent UK Biobank analysis shows healthy dietary patterns can extend lifespan by 1.5-3.0 years, emphasizing diet as a key modifiable factor for longevity and healthspan extension. New data from UK Bio...
A new blood test based on p-tau217 biomarker can predict Alzheimer’s symptom onset in 3-4 years with high accuracy, offering early intervention opportunities. Recent studies validate a p-tau217 ...
New evidence supports menopausal hormone therapy for reducing mortality and enhancing healthspan, with updated guidelines emphasizing personalized approaches based on recent studies and expert insight...
New research reveals Ube2g1 upregulation in hematopoietic stem cells drives immune senescence via tyrosine phosphorylation, offering insights for reversing age-related decline, based on Haematologica ...
Emerging research links aging oral microbiome with senescent cells to amplify systemic inflammation, driving diseases like Alzheimer’s and offering new intervention targets such as probiotics an...
The ARMOR clinical trial investigates FMT from young, active donors to older adults to enhance muscle, cognitive, and metabolic health, addressing gut dysbiosis for aging resilience. A groundbreaking ...
Recent studies show that targeting engrams with partial reprogramming factors improves memory in mouse models, offering a potential therapy for Alzheimer’s and age-related cognitive decline. New...
New research on position effect variegation in Drosophila reveals epigenetic aging markers, linking heterochromatin stability to longevity and informing anti-aging therapies. Recent studies show PEV i...
A 2024 study in Nature Aging shows transferring young gut bacteria to aged mice rejuvenates intestinal stem cells via Wnt signaling, suggesting FMT’s potential for age-related disorders. Recent ...
